Buscador de publicacions

Publicacions

  • Tomás-Daza L, Rovirosa L, López-Martí P, Nieto-Aliseda A, Serra F, Planas-Riverola A, Molina O, McDonald R, Ghevaert C, Cuatrecasas E, Costa D, Camós-Guijosa M, Bueno C, Menéndez P, Valencia A and Javierre BM.

    Low input capture Hi-C (liCHi-C) identifies promoter-enhancer interactions at high-resolution

    NATURE COMMUNICATIONS . 14(1): 268-268. Nº de cites: 1

    [doi:10.1038/s41467-023-35911-8]

  • Moran Alvarez, Patricia, Andreu-Suarez, Africa, Caballero-Mota, Liz, Gassiot S, Berrueco R, Calzada-Hernández J, Vazquez-Diaz, Monica, Boteanu, Alina, Messia, Virginia, Giovannelli, Luigi, De Benedetti, Fabrizio, Anton-Lopez J and Bracaglia, Claudia.

    Haematological and other manifestations in the presence of antiphospholipid antibodies in a multicentric paediatric cohort.

    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY . 41(11): 2331-2337.

    [doi:10.55563/clinexprheumatol/3mzh06]

  • Pallarès N, Tebé C, Abelenda-Alonso G, Rombauts A, Oriol I, Simonetti AF, Rodríguez-Molinero A, Izquierdo E, Diaz de Brito V, Molist G, Gómez Melis G, Carratalà J and Videla S.

    Characteristics and Outcomes by Ceiling of Care of Subjects Hospitalized with COVID-19 During Four Waves of the Pandemic in a Metropolitan Area: A Multicenter Cohort Study.

    Infectious Diseases and Therapy . 12(1): 1-17.

    [doi:10.1007/s40121-022-00705-w]

  • Santoro C, Fuh B, Le PQ, Maes P, Berrueco R, Mingot-Castellano EM, von Mackensen S, Tueckmantel C, Cabre-Marquez JF and Wang M.

    Efficacy and safety in patients with haemophilia A switching to octocog alfa (BAY 81-8973): Final results of the global real-world study, TAURUS

    EUROPEAN JOURNAL OF HAEMATOLOGY . 110(1): 77-87. Nº de cites: 1

    [doi:10.1111/ejh.13876]

  • Margarit-Soler A, Deyà-Martinez A, Canizales JT, Vlagea A, García-García AP, Marsal-Ricoma J, Del Castillo MT, Planas-Roman S, Simó-Nebot S, Esteve-Solé A, Grande MS, Badell-Serra I, Tarrats MR, Fernández-Avilés F and Alsina L.

    Case report: Challenges in immune reconstitution following hematopoietic stem cell transplantation for CTLA-4 insufficiency-like primary immune regulatory disorders

    FRONTIERS IN IMMUNOLOGY . 13: 1070068-1070068. Nº de cites: 4

    [doi:10.3389/fimmu.2022.1070068]

  • Salmerón-Villalobos J, Ramis-Zaldivar JE, Balagué O, Verdú-Amorós J, Celis-Passini V, Sábado C, Garrido M, Mato S, Uriz J, Ortega MJ, Gutierrez-Camino A, Sinnett D, Illarregi U, Carron M, Regueiro A, Galera A, Gonzalez-Farré B, Campo E, Garcia N, Colomer D, Astigarraga I, Andrés M, Llavador M, Martin-Guerrero I and Salaverria I.

    Diverse mutations and structural variations contribute to Notch signaling deregulation in paediatric T-cell lymphoblastic lymphoma

    PEDIATRIC BLOOD & CANCER . 69(11): . Nº de cites: 4

    [doi:10.1002/pbc.29926]

  • Kotmayer L, Romero-Moya D, Marin-Bejar O, Kozyra E, Català-Temprano A, Bigas A, Wlodarski MW, Bödör C and Giorgetti A.

    GATA2 deficiency and MDS/AML: Experimental strategies for disease modelling and future therapeutic prospects.

    BRITISH JOURNAL OF HAEMATOLOGY . 199(4): 482-495. Nº de cites: 7

    [doi:10.1111/bjh.18330]

  • Núñez R, Álvarez-Román MT, Bonanad S, González-Porras JR, De La Corte-Rodriguez H, Berrueco R and Jiménez-Yuste V.

    The Limitations and Unmet Needs of the Five Cornerstones to Guarantee Lifelong Optimization of Prophylaxis in Hemophilia Patients.

    th open : companion journal to thrombosis and haemostasis . 6(4): 365-377. Nº de cites: 1

    [doi:10.1055/s-0042-1757745]

  • Hinojosa J, Simó-Nebot M, Armero-Campos G, Becerra MV, Alamar AM, Candela-Cantó SA, Culebras D, Muchart-Lopez J and Berrueco R.

    Hemophilia and non-accidental head trauma in two siblings: lessons and legal implications

    CHILDS NERVOUS SYSTEM . 38(12): 2415-2423.

    [doi:10.1007/s00381-022-05713-2]

  • Ghorashian S, Jacoby E, De Moerloose B, Rives-Solà S, Bonney D, Shenton G, Bader P, Bodmer N, Quintana AM, Herrero B, Algeri M, Locatelli F, Vettenranta K, Gonzalez B, Attarbaschi A, Harris S, Bourquin JP and Baruchel A.

    Tisagenlecleucel therapy for relapsed or refractory B-cell acute lymphoblastic leukaemia in infants and children younger than 3 years of age at screening: an international, multicentre, retrospective cohort study.

    The Lancet. Haematology . 9(10): 766-775. Nº de cites: 7

    [doi:10.1016/S2352-3026(22)00225-3]